Marburg virus disease outbreaks, mathematical models, and disease parameters: a systematic review
Open accessPublished version of a preprint
The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index; 34 of the 55 sources its claims cite were checked for support.
Abstract
The 2023 Marburg virus disease outbreaks in Equatorial Guinea and Tanzania highlighted the importance of better understanding this lethal pathogen. We did a systematic review (PROSPERO CRD42023393345) of peer-reviewed articles reporting historical outbreaks, modelling studies, and epidemiological parameters focused on Marburg virus disease. We searched PubMed and Web of Science from database inception to March 31, 2023. Two reviewers evaluated all titles and abstracts with consensus-based decision making. To ensure agreement, 13 (31%) of 42 studies were double-extracted and a custom-designed quality assessment questionnaire was used for risk of bias assessment. We present detailed information on 478 reported cases and 385 deaths from Marburg virus disease. Analysis of historical outbreaks and seroprevalence estimates suggests the possibility of undetected Marburg virus disease outbreaks, asymptomatic transmission, or cross-reactivity with other pathogens, or a combination of these. Only one study presented a mathematical model of Marburg virus transmission. We estimate an unadjusted, pooled total random effect case fatality ratio of 61·9% (95% CI 38·8-80·6; I 2=93%). We identify epidemiological parameters relating to transmission and natural history, for which there are few estimates. This systematic review and the accompanying database provide a comprehensive overview of Marburg virus disease epidemiology and identify key knowledge gaps, contributing crucial information for mathematical models to support future Marburg virus disease epidemic responses.
Overview
CoChat Summary
TL;DR
This systematic review collates Marburg virus disease (MVD) outbreaks, mathematical models, and epidemiological parameters up to 31 March 2023, reporting 478 cases and 385 deaths across identified outbreaks. It finds only one transmission modelling study, a pooled random-effect case fatality ratio of 61.9% (95% CI 38.8–80.6%), and substantial gaps in parameters needed for outbreak modelling.
Key findings
- The review collated evidence from 13 studies reporting 23 observed MVD outbreaks, identifying seven distinct outbreaks, with 478 reported cases and 385 deaths; only two outbreaks had over 100 confirmed cases (DRC 1998: 154 cases; Angola 2005: 254 cases).
- Only one study presented a mathematical model of MVD transmission: a stochastic, individual-based SEIR model by Ajelli et al., which estimated R0 = 1.59 (95% CI 1.53–1.66) for the 2005 Angola outbreak and a doubling time of 12.4 days (95% CI 11.3–13.6 days); Borchert et al. estimated an effective reproduction number Re = 0.93 after public health and social measures, and an attack rate of 21%.
- Pooled CFR estimates were high: total random effect CFR 61.9% (95% CI 38.8–80.6%, I2=93%) and total common effect CFR 80.6% (95% CI 77.3–83.6%, I2=93%); from extracted outbreak data, random effect CFR was 63.8% (95% CI 41.6–81.3%, I2=82%) and common effect CFR 80.5% (95% CI 76.7–83.8%, I2=82%).
- Seroprevalence was the most frequently reported parameter, from 21 studies over 1980–2018 in 15 predominantly Sub-Saharan African countries; about one third reported 0% seroprevalence, and nonzero estimates ranged from 0.5% in the Republic of the Congo in 2011 to 2.1% in healthcare workers in DRC in 2001–2002 and 4.5% in Uganda in 1984, suggesting possible undetected outbreaks, asymptomatic transmission, and/or cross-reactivity.
Methods
- Systematic review (PROSPERO CRD42023393345) reported according to PRISMA; PubMed and Web of Science were searched until 31 March 2023, with two independent reviewers screening titles and abstracts then full texts, resolving disagreements by consensus; 42 studies were included for data extraction.
- Data on article information, estimated parameters, outbreaks, and models were extracted into a Microsoft Access database; 31% (13/42) of studies were double-extracted, and risk of bias was assessed with a custom seven-question quality assessment form.
- Descriptive tables and figures were used; CFR meta-analyses used the meta R package to produce total common effect and total random effect pooled estimates with 95% CIs and heterogeneity statistics, and an unadjusted CFR was computed from extracted outbreak data.
Limitations
- The paper states that findings are constrained by restriction to peer-reviewed articles in English, which is particularly important because many countries with reported MVD outbreaks are not English-speaking; extending to non-English and non-peer-reviewed work would be challenging.
- The paper states that no unique validated quality assessment tool existed for the broad range of studies, so a tailored scoring system was constructed; many parameters had few estimates, often only point estimates without uncertainty, and some estimates were from the previous century or based on poor-quality data.
- The paper states that seroprevalence estimates must be interpreted in the context of very small sample sizes in most studies; the text also makes evident that only one transmission model was found, no peer-reviewed studies on the 2023 Equatorial Guinea and Tanzania outbreaks were available at the search time, and odds ratios were not extracted because varying stratifications and reference groups complicate comparison.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
20 Valid · 3 Not valid · 13 Not checked · 76 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“They found that R0 = 1.59 (95% CI: 1.53–1.66), suggesting that in the absence of mitigation efforts, the virus would be expected to propagate in a similar population (24).”
§ Marburg Virus Disease outbreaks, mathematical models, and disease parameters: a Systematic Review > Results
What the sources say
- Supportedcites [24] 24. Ajelli M, Merler S. Transmission potential and design of adequate control measures for Marburg hemorrhagic fever. PloS One. 2012;7(12):e50948. doi: 10.1371/journal.pone.0050948. source
The Results (Basic Reproduction Number; page unavailable) report R₀ = 1.59 (95% CI: 1.53–1.66). The Results (Baseline Scenario; page unavailable) simulate substantial spread in a fully susceptible population without control measures, supporting the inference, while noting that an introduced infection does not always cause a large outbreak. (LLM, conf=0.91)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This study also provided the only estimate of attack rate, at 21% (Figure 3).”
§ Marburg Virus Disease outbreaks, mathematical models, and disease parameters: a Systematic Review > Results
What the sources say
- Partly supportedcites [25] 25. Borchert M, Mulangu S, Swanepoel R, Libande ML, Tshomba A, Kulidri A, et al. Serosurvey on household contacts of Marburg hemorrhagic fever patients. Emerg Infect Dis. 2006;12(3):433–9. doi: 10.3201/eid1203.050622. sourceExperimental — accuracy not yet measured
The Results section (“Secondary Attack Risk and Postintervention Rp”) estimates a 21% secondary attack risk for household contacts. The paper does not establish that this was the only attack-rate estimate across studies; it also reports a 19% tertiary attack risk. (LLM, conf=0.84)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Borchert et al. estimated the effective reproduction number, Re, based on secondary attack rates derived from seroprevalence in contacts of confirmed cases in DRC in 2002 (25).”
§ Marburg Virus Disease outbreaks, mathematical models, and disease parameters: a Systematic Review > Results
What the sources say
- Partly supportedcites [25] 25. Borchert M, Mulangu S, Swanepoel R, Libande ML, Tshomba A, Kulidri A, et al. Serosurvey on household contacts of Marburg hemorrhagic fever patients. Emerg Infect Dis. 2006;12(3):433–9. doi: 10.3201/eid1203.050622. sourceExperimental — accuracy not yet measured
The Methods (Data Analysis) and Results (Secondary Attack Risk and Postintervention Rp) show that Borchert et al. estimated a postintervention reproduction number from household secondary attack risk. But the risk was calculated from secondary cases and healthy contacts, not directly from the reported seroprevalence; the main calculation was not restricted to contacts of confirmed primary cases. The paper identifies 2002 as the survey year, while the outbreak ended in 2000. (LLM, conf=0.84)
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“They found that R0 = 1.59 (95% CI: 1.53–1.66), suggesting that in the absence of mitigation efforts, the virus would be expected to propagate in a similar population (24).”
§ Marburg Virus Disease outbreaks, mathematical models, and disease parameters: a Systematic Review > Results
What the sources say
- Supportedcites [24] 24. Ajelli M, Merler S. Transmission potential and design of adequate control measures for Marburg hemorrhagic fever. PloS One. 2012;7(12):e50948. doi: 10.1371/journal.pone.0050948. source
The Discussion explicitly estimates the basic reproduction number for the 2005 Marburg outbreak in Angola as 1.59 (95% CI: 1.53–1.66). The Materials and Methods section defines R0 for a fully susceptible population, and the Results’ Baseline Scenario describes simulated spread without control measures. (LLM, conf=0.95)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Central estimates of time from symptom onset to careseeking across the 1975 South Africa, 1998 DRC, and 2012 Uganda outbreaks were consistently under 5 days, although Bausch et al. showed a large range of delays from symptoms to seeking medical care (17,27,30) for the 1998 DRC outbreak.”
§ Marburg Virus Disease outbreaks, mathematical models, and disease parameters: a Systematic Review > Results
What the sources say
- Supportedcites [17] 17. Bausch DG, Nichol ST, Muyembe-Tamfum JJ, Borchert M, Rollin PE, Sleurs H, et al. Marburg hemorrhagic fever associated with multiple genetic lineages of virus. N Engl J Med. 2006;355(9):909–19. doi: 10.1056/NEJMoa051465. source
In the Clinical Presentation and Case Fatality Rate section, our copy reports that of 150 DRC (Durba/Watsa, onset from October 1998) patients, 97 sought medical care and presented a median of 4.5 days after symptom onset, with a range of 0 to 24 days. This supports both elements attributed to Bausch et al.: a central estimate under 5 days for the 1998 DRC outbreak and a large spread of delays. The 1975 South Africa and 2012 Uganda figures in the citing sentence carry other citation numbers and are not part of what this source is offered for. (LLM, conf=0.90)
- Partly supportedcites [27] 27. Knust B, Schafer IJ, Wamala J, Nyakarahuka L, Okot C, Shoemaker T, et al. Multidistrict Outbreak of Marburg Virus Disease-Uganda, 2012. J Infect Dis. 2015;212 Suppl 2:S119-28. doi: 10.1093/infdis/jiv351. sourceExperimental — accuracy not yet measured
The Results report that confirmed and probable cases in the 2012 Uganda outbreak were hospitalized a mean of 4 days after symptom onset, supporting an under-5-day estimate for that outbreak. Hospitalization is not necessarily the first time a patient sought care, and the paper does not give comparable care-seeking estimates for the 1975 South Africa or 1998 DRC outbreaks. (LLM, conf=0.88)
- Partly supportedcites [30] 30. Gear JSS, Cassel GA, Gear AJ, Trappler B, Clausen L, Meyers AM, et al. OUTBREAK OF MARBURG VIRUS DISEASE IN JOHANNESBURG. Br Med J. 1975;4(5995):489–93. doi: 10.1136/bmj.4.5995.489. sourceExperimental — accuracy not yet measured
Our copy of Gear et al. (1975) supports only the 1975 South Africa component, and only implicitly: the Case 1 report (Case 1 section) states the index patient was admitted to Johannesburg Hospital on 15 February 1975 having 'been ill for four days', and the Case 2 report (Case 2 section) places her admission on 22 February, two days after she became ill — i.e. per-patient onset-to-presentation intervals under 5 days. The paper never computes or states a 'central estimate' of time from symptom onset to careseeking, and its Discussion deals with incubation period and clinical features rather than careseeking delay. The 1998 DRC and 2012 Uganda elements of the claim are absent from this paper entirely, so the cross-outbreak 'consistently under 5 days' assertion rests on the other cited works, not on this source. (LLM, conf=0.72)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
48 more claims · 11 with their cited sources checked
Create a free account to see all 112 claims and to verify the 5 references still open.
- Probably not a substantial claim. 37
- It may state two separate claims as one. 34
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Marburg Virus Disease outbreaks, mathematical models, and disease parameters: a Systematic Review > Discussion
“DRC 1998: 154 cases, Angola 2005: 254 cases”
§ Marburg Virus Disease outbreaks, mathematical models, and disease parameters: a Systematic Review > Results
“| | Palvin 2014 | (§) | 2004 | 2005 | 227 | 252 |”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Marburg Virus Disease outbreaks, mathematical models, and disease parameters: a Systematic Review > Discussion
“the two large outbreaks in Angola and Uganda”
§ Marburg Virus Disease outbreaks, mathematical models, and disease parameters: a Systematic Review > Discussion
“Only two outbreaks had over 100 confirmed cases (DRC 1998: 154 cases, Angola 2005: 254 cases)”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| Bausch 2003 | May 1999 | IgG | 2.00% | | | 15 | 912 |”
§ Marburg Virus Disease outbreaks, mathematical models, and disease parameters: a Systematic Review > Results
Reported 2 · recomputed 1.644737
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Marburg Virus Disease outbreaks, mathematical models, and disease parameters: a Systematic Review > Abstract
“31% (13/42) of studies were double-extracted”
§ Marburg Virus Disease outbreaks, mathematical models, and disease parameters: a Systematic Review > Methods > Data extraction
“For a randomly selected 30% (13/43) of papers, extraction was performed by two independent reviewers.”
Citations
Cites
The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · International Journal of Surgery · doi:10.1016/j.ijsu.2021.105906 · Cited by 11,748
How to perform a meta-analysis with R: a practical tutorial
Balduzzi, S., Rücker, G., & Schwarzer, G. (2019) · Evidence Based Mental Health · doi:10.1136/ebmental-2019-300117 · Cited by 5,827
Doing Meta-Analysis with R: A Hands-On Guide
Harrer, M., Cuijpers, P., Furukawa, T. A., & Ebert, D. D. (2021) · doi:10.1201/9781003107347 · Cited by 1,850
Ebola virus disease in West Africa—the first 9 months of the epidemic and forward projections
WHO Ebola Response Team (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1411100 · Cited by 1,674
Davies, N. G., Kucharski, A. J., Eggo, R. M., Gimma, A., Edmunds, W. J., Jombart, T., O'Reilly, K., Endo, A., Hellewell, J., Nightingale, E. S., et al. (2020) · The Lancet Public Health · doi:10.1016/s2468-2667(20)30133-x · Cited by 848 · cited 1×
“Infectious disease outbreaks pose a substantial threat to health and well-being globally [1, 2, 3].”
Smith, R. D. (2006) · Social Science & Medicine · doi:10.1016/j.socscimed.2006.08.004 · Cited by 759 · cited 1×
“Infectious disease outbreaks pose a substantial threat to health and well-being globally [1, 2, 3].”
Amman, B. R., Carroll, S. A., Reed, Z. D., Sealy, T. K., Balinandi, S., Swanepoel, R., Kemp, A., Erickson, B. R., Comer, J. A., Campbell, S., et al. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002877 · Cited by 453 · cited 11×
“We searched PubMed and Web of Science for published mathematical transmission models and articles reporting on MVD transmission, evolution, natural history, severity, seroprevalence and size of previous outbreaks, published prior to 31 March 2023 (see the Supplementary Information A.1 for search strategy).”
InfluentialMarburgvirus Genomics and Association with a Large Hemorrhagic Fever Outbreak in Angola
Towner, J. S., Khristova, M. L., Sealy, T. K., Vincent, M. J., Erickson, B. R., Bawiec, D. A., Hartman, A. L., Comer, J. A., Zaki, S. R., Ströher, U., et al. (2006) · Journal of Virology · doi:10.1128/jvi.00069-06 · Cited by 378
Outbreake of Marburg virus disease in Johannesburg
Gear, J. S., Cassel, G. A., Gear, A. J., Trappler, B., Clausen, L., Meyers, A. M., Kew, M. C., Bothwell, T. H., Sher, R., Miller, G. B., et al. (1975) · BMJ · doi:10.1136/bmj.4.5995.489 · Cited by 352 · cited 2×
“The two incubation period estimates came from studies from the 1970s only reporting ranges with little overlap [26, 22] (Figure 3).”
Marburg-virus disease in Kenya
Smith, D. H., Isaacson, M., Johnson, K. M., Bagshawe, A., Johnson, B. K., Swanapoel, R., Killey, M., Siongok, T., & Koinange Keruga, W. (1982) · The Lancet · doi:10.1016/s0140-6736(82)91871-2 · Cited by 324 · cited 1×
“The studies included in this review demonstrated low levels of antibodies in surveyed populations, with approximately one third of studies reporting a seroprevalence of 0% (26,36,39,41,46,50,52).”
Research works printed but not linked: 1
- 21. Covidence - Better systematic review management [Internet] [cited 2023 Jul 26]. Available from: https://get.covidence.org/systematic-review.
Cited by
Charniga, K., Park, S. W., Akhmetzhanov, A. R., Cori, A., Dushoff, J. G., Funk, S., Gostic, K. M., Linton, N. M., Lison, A., Overton, C. E., et al. (2024) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1012520 · Cited by 50
“Consider using the approach of Reich and colleagues [44] or Ward and colleagues’ double interval censoring corrected model [23,24] to obtain estimates that are not adjusted for right truncation.”
MethodSelf-citationBat organoids reveal antiviral responses at epithelial surfaces
Kellner, M. J., Monteil, V., Zelger, P., Pei, G., Jiao, J., Onji, M., Nayak, K., Zilbauer, M., Balkema‐Buschmann, A., Dorhoi, A., et al. (2025) · Nature Immunology · doi:10.1038/s41590-025-02155-1 · Cited by 35
“Given the disparate disease outcomes of MARV infection in R. aegyptiacus bats 7 compared to humans 34 , together with a suspected infection route via mucosal surfaces in these species 35 ,”
Gaetano, S. D., Ponzo, E., Midiri, A., Mancuso, G., Filippone, D., Infortuna, G., Zummo, S., & Biondo, C. (2025) · Hygiene · doi:10.3390/hygiene5020018 · Cited by 42
Inference of epidemic dynamics in the COVID-19 era and beyond
Cori, A., & Kucharski, A. J. (2024) · Epidemics · doi:10.1016/j.epidem.2024.100784 · Cited by 20
Self-citationMedjoudja, M., Mezabia, M. E. H., Riaz, M. B., et al. (2024) · AIMS Mathematics · doi:10.3934/math.2024642 · Cited by 16
Metadata
- Authors
- Cuomo-Dannenburg, G., McCain, K., McCabe, R., Unwin, H. J. T., Doohan, P., Nash, R. K., Hicks, J. T., Charniga, K., Geismar, C., Lambert, B., Nikitin, D., Skarp, J., Wardle, J., Kont, M., Bhatia, S., Imai, N., van Elsland, S., Cori, A., Morgenstern, C., Morris, A., Forna, A., Dighe, A., Cori, A., Hamlet, A., Lambert, B., Whittaker, C., Morgenstern, C., Geismar, C., Nikitin, D., Jorgensen, D., Knock, E., Unwin, E., Cuomo-Dannenburg, G., Thompson, H., Routledge, I., Skarp, J., Hicks, J., Fraser, K., Charniga, K., McCain, K., Geidelberg, L., Cattarino, L., Kont, M., Baguelin, M., Imai, N., Moghaddas, N., Doohan, P., Nash, R., McCabe, R., van Elsland, S., Bhatia, S., Radhakrishnan, S., Cucunuba Perez, Z., & Wardle, J.
- Affiliations
- Imperial College London (GB)
- University of Liverpool (GB)
- ORCID
- Venue
- The Lancet Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2024-05
- Volume
- 24
- Issue
- 5
- Pages
- e307-e317
- ISSN
- 1473-3099 (ISSN-L)
- PMC
- PMC7615873
- OpenAlex
- W4389074224
- Cited by
- 65
- References
- 62
- Citations by year
- 2026: 29 · 2025: 20 · 2024: 16
- FWCI
- 2.51
- Type
- journal article
- Language
- en
- Open access
- green
- dx.doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- The Lancet Infectious Diseases (publishedVersion)
- medRxiv (submittedVersion, cc-by)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by)
- PubMed Central (acceptedVersion, cc-by)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Explore Bristol Research (submittedVersion, cc-by-nd)
- Bristol Research (University of Bristol) (submittedVersion, cc-by-nd)
- Spiral (Imperial College London) (submittedVersion, other-oa)
- Funders
- Wellcome Trust
- The Schmidt Family Foundation
- UKRI Medical Research Council
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Outbreaks Research
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Vectors
- Physical Sciences › Mathematics › Applied Mathematics › Mathematical and Theoretical Epidemiology and Ecology Models
- Keywords
- Marburg virus disease, outbreak epidemiology, mathematical transmission model, case fatality rate, seroprevalence, asymptomatic transmission, cross-reactivity, natural history of disease, disease severity, transmission delay, risk factors, mutation rate, Equatorial Guinea, Tanzania
- MeSH terms
- Animals, Disease Outbreaks, Humans, Marburg Virus Disease, Models, Theoretical, Seroepidemiologic Studies, Marburgvirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Marburg virus disease outbreaks, mathematical models, and disease parameters: a systematic review. https://app.cochat.ai/papers/10.1016/s1473-3099(23)00515-7
- The paper
- Cuomo-Dannenburg, G., McCain, K., McCabe, R., Unwin, H. J. T., Doohan, P., Nash, R. K., Hicks, J. T., Charniga, K., Geismar, C., Lambert, B., Nikitin, D., Skarp, J., Wardle, J., Kont, M., Bhatia, S., Imai, N., van Elsland, S., Cori, A., Morgenstern, C., . . . Wardle, J. (2024). Marburg virus disease outbreaks, mathematical models, and disease parameters: a systematic review. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(23)00515-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.



